| Symptom | Non-cases (n = 29) |
Cases (n = 81)a |
|||
|---|---|---|---|---|---|
| nb | Median duration in days (IQR)c | n | % | Median duration in days (IQR)c | |
| Cough | 9 | 3 (2–6) | 67 | 83 | 4 (3–5) |
| Runny/stuffy nose | 10 | 4 (2–12) | 63 | 78 | 4 (2–5) |
| Fatigue/lethargy | 6 | 3 (2–4) | 60 | 74 | 4 (2–5) |
| Sore throat | 11 | 2.5 (1–6) | 58 | 72 | 3 (2–5) |
| Headache | < 5 | – | 55 | 68 | 2 (2–4) |
| Muscle pain | < 5 | – | 47 | 58 | 2.5 (2–4) |
| Fever | < 5 | – | 44 | 54 | 2 (2–3) |
| Sneezing | 10 | 4 (2–9) | 35 | 43 | 3 (2–4) |
| Reduced smell | < 5 | – | 10 | 12 | 2 (2–3) |
| Reduced appetite | < 5 | – | 27 | 33 | 3 (2–5) |
| Heavy breathing | – | – | 10 | 12 | 2 (1–5) |
| Reduced taste | < 5 | – | 19 | 23 | 2.5 (2–4) |
| Abdominal pain | < 5 | – | 5 | 6 | 2 (1–3) |
| Any of the above listed symptoms | 19 | 4 (3–7) | 80 | 99 | 6 (5–8) |
IQR: interquartile range; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2. a One confirmed case was asymptomatic and therefore not included. b Symptoms reported by less than five participants are reported as < 5. c Duration of symptoms might have been underestimated for some participants if the symptoms were still present after the day they were interviewed. Five non-cases and 62 cases reported still having symptoms on the day they were interviewed. | |||||